Millie Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-4,373
Closed -$246K 73
2016
Q4
$246K Sell
4,373
-3,364
-43% -$197K 0.25% 65
2016
Q3
$461K Hold
7,737
0.51% 47
2016
Q2
$425K Hold
7,737
0.45% 50
2016
Q1
$391K Buy
7,737
+469
+6% +$23K 0.42% 53
2015
Q4
$366K Sell
7,268
-205
-3% -$10.3K 0.38% 59
2015
Q3
$352K Hold
7,473
0.32% 61
2015
Q2
$406K Hold
7,473
0.37% 53
2015
Q1
$410K Hold
7,473
0.38% 54
2014
Q4
$405K Buy
+7,473
New +$416K 0.42% 53

Other funds holding MRK

Millie Capital Management's MRK Position: Q1 2017 in Review

Millie Capital Management sold out of Merck (MRK) in Q1 2017, closing a stake of 4,373 shares — an estimated $246K sold.

Millie Capital Management first reported a position in MRK in Q4 2014 and held it in 9 quarters. The position peaked at $461K in Q3 2016. 1,941 funds tracked by Wall St. Rank hold MRK as of Q1 2017.

  • Millie Capital Management reported no remaining Merck position as of Q1 2017 after selling out during the quarter.
  • Millie Capital Management sold 4,373 Merck shares in Q1 2017, an estimated $246K.
  • Millie Capital Management first reported a position in Merck in Q4 2014 and held it in 9 quarters.
  • Millie Capital Management's Merck position peaked at $461K in Q3 2016.
  • 1,941 funds tracked by Wall St. Rank held Merck as of Q1 2017.

Based on Millie Capital Management's 13F filing for Q1 2017, filed 1 May 2017.